Bioequivalence Study of Cefprozil Tablets, USP 500 mg Undef Fed Conditions
Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the single - dose relative bioavailability of
Ranbaxy and Bristol-Myers Squibb Company (CEFZIL ®) 500 mg cefprozil tablets, under fed
conditions.